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Background. Free nitric oxide (NO) reacts with sulphydryl residues to form S-nitrosothiols, which act as NO reservoirs. We
sought to determine whether thiol-preserving agents and antioxidants, such as dithiothreitol (DTT) and vitamin C, induce NO
release from S-nitrosylated proteins in endothelial cell cultures to promote angiogenesis. Methodology/Principal Findings.
NO release was measured directly in cell supernatants using a Sievers NO Analyser, and in vitro angiogenesis was assessed by
quantifying capillary-like tube network formation of porcine aortic endothelial cells (PAEC) on growth factor-reduced Matrigel.
Incubation of PAEC with DTT or vitamin C significantly increased NO release in a concentration-dependent manner. However,
the nitric oxide synthase (NOS) inhibitors, L-NNA and L-NIO, had no effect on DTT- or vitamin C-induced NO release, and there
was no concomitant increase in the phosphorylation of endothelial NOS at serine-1177 following DTT or vitamin C treatment.
DTT and vitamin C increased capillary-like tube network formation by nine- and two-fold, respectively, and the addition of
copper ions doubled the effect of vitamin C. Surprisingly, DTT maintained endothelial tube networks for up to one month
under serum-free conditions, and selective inhibitors of guanylyl cyclase (ODQ) and PKG (KT-5823) blocked this, demonstrating
the requirement of cyclic GMP and PKG in this process. Conclusions/Significance. Both DTT and vitamin C are capable of
releasing sufficient NO from S-nitrosothiols to induce capillary morphogenesis. This study provides the first evidence that
increased denitrosylation leads to increased bioavailability of NO, independent of NOS activity, to promote sustained
angiogenesis.
Citation: Al-Ani B, Hewett PW, Ahmed S, Cudmore M, Fujisawa T, et al (2006) The Release of Nitric Oxide from S-Nitrosothiols Promotes
Angiogenesis. PLoS ONE 1(1): e25. doi:10.1371/journal.pone.0000025
INTRODUCTION
Nitric oxide (NO), generated by endothelial NO synthase (eNOS),
is a key regulator of vascular function [1]. The physiological
actions of NO are mediated predominantly via the activation of
soluble guanylyl cyclase leading to generation of the potent second
messenger cyclic guanosine monophosphate (cGMP) from guano-
sine 59-triphosphate (GTP) [2,3]. Cyclic GMP in turn activates
cGMP-dependent kinases, such as protein kinase G (PKG),
culminating in the regulation of many functions including the
control of vascular tone, inhibition of platelet aggregation and
neutrophil adhesion to endothelium, and reduction of vascular
smooth muscle cell proliferation [4,5]. NO is also a critical
mediator of vascular endothelial cell growth factor (VEGF)-
induced angiogenesis as VEGF fails to induce angiogenesis in
eNOS
2/2 knock-out mice [6,7] and eNOS inhibitors block
VEGF-induced angiogenesis [8,9].
NO reacts rapidly with free sulphydryl groups to form S-
nitrosothiols [10]. Circulating free NO has a very short half-life
[11,12], and the majority reacts with sulphydryl-containing
proteins such as serum albumin that act as NO reservoirs
dramatically increasing its half-life [10,13–15]. Patients undergo-
ing chronic hemodialysis have reduced NO activity due to
increased levels of S-nitrosothiol-albumin, which represents an
independent prognostic indicator of cardiovascular events [16]. S-
nitrosoproteins have been detected in many cell types including
endothelial cells [14], and S-nitrosylation is now recognised as
a major post-translational modification that can affect the
functional activity of proteins [17]. In addition, glutathione is
the main non-protein that is S-nitrosylated in cells and
extracellular fluids [18]. S-nitrosothiols are sensitive to reduction,
and in the circulation they are denitrosylated by agents such as
vitamin C, cysteine and reduced glutathione to release NO
[19,20]. Recent evidence from mice deficient in S-nitrosoglu-
tathione reductase demonstrates that it is essential for
S-nitrosothiol metabolism and highlights the critical role of
S-nitrosothiols in NO biology and vascular homeostasis [21].
However, the significance of NO released from S-nitrosothiol
reservoirs, in response to stimulation with thiol preserving agents
and antioxidants, on endothelial cell function and angiogenesis has
not been evaluated.
In this study we examined the contribution of NO-release from
S-nitrosothiols on in vitro angiogenesis. NO production was assayed
directly in porcine aortic endothelial cells (PAEC) treated with
DTT or vitamin C in the presence and absence of the NOS
inhibitors, L-NG Nitroarginine (L-NNA) and L-N
5-(-1-Iminoethy-
l)ornithine dihydrochloride (L-NIO) using a Sievers NOA 280
chemiluminescence analyzer. Both DTT and vitamin C were
found to produce sufficient NO-release, in the absence of NOS
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PAEC were grown in full growth medium consisting of HAM F12
nutrient mixture supplemented with 25 mML -glutamine, 100 U/
ml Penicillin and 100 mg/ml Streptomycin sulphate and 10% fetal
calf serum (FCS) and cultured as described previously [9]. All cell
culture reagents were obtained from Sigma (Poole, Dorset, UK)
unless stated otherwise.
Measurement of NO Release
PAEC were seeded at 1610
5 cells per well in 24-well plates
containing full growth medium. All stimulations were performed
with confluent quiescent cell monolayers in serum-free medium
consisting of HAM F12 nutrient mixture supplemented with
25 mML -glutamine, 100 U/ml penicillin and 100 mg/ml strepto-
mycin sulphate and 0.2% bovine serum albumin (BSA). Cells were
treated with various concentrations of DTT (Sigma) or vitamin C
(Aldrich) in a final volume of 0.5 ml at 37uC for 60 minutes and
the supernatants harvested and stored at 280uC for NO analysis.
For the experiments using pharmacological inhibitors, PAEC were
pre-incubated for 30 minutes with L-NNA or L-NIO (Merck
Biosciences), at the concentrations indicated, prior to DTT or
vitamin C stimulation. NO was measured directly in the gas phase,
using a Sievers NOA 280 chemiluminescence analyzer (Analytix,
Sunderland, UK) as described previously [22]. The level of NO
detected in cell supernatants were corrected for background by
subtracting the amount of NO present in serum-free endothelial
cell culture medium incubated under the same conditions in the
absence of PAEC.
Tube formation assay
The formation of capillary-like tubular structures was studied on
growth factor-reduced Matrigel (Becton Dickinson Labware)
diluted 1:1 in ice-cold serum-free medium, as described previously
[9]. PAEC were seeded at a density of 6610
4 cells per well on
Matrigel-coated 24 well dishes in full growth medium for 2 hours
at 37uC. The growth medium was removed and DTT, vitamin C
or the vehicle alone added in serum-free medium containing 0.2%
bovine serum albumin (BSA). For the studies using pharmacolog-
Figure 1. The effect of DTT and vitamin C on NO-release and eNOS activation in endothelial cells.( A): Porcine aortic endothelial cells (PAEC) were
grown to confluence in 24-well plates and stimulated with increasing concentrations of DTT and vitamin C for 1 hour and NO measured in the
supernatants. (B): Total NO release from PAEC following 1 hour incubation with 500 mM DTT and vitamin C in the absence or presence of the NOS
inhibitor, L-NNA (500 mM). NO was measured directly using a Sievers NOA 280 chemiluminescene analyzer and the results were corrected for
background levels of NO present in the medium. Results are the mean (6SEM, bars) of two experiments (n=12), *p,0.01 versus control. (C): Western
blots showing the effect of increasing concentrations of DTT, vitamin C or phorbol myristate acetate (PMA) on the phosphorylation of eNOS
(phospho-eNOS) at serine-1177 in PAEC after 15 min. (D): Western blot showing the presence of S-nitrosylated proteins of PAEC pre-treated with
30 mM SNAP (lanes 1–3) or vehicle (lane 4) for 1 hour and then incubated with 500 mmol/L DTT (lane 2) or 500 mM vitamin C (lane 3) or vehicle (lanes
1 and 4) for 1 hour.
doi:10.1371/journal.pone.0000025.g001
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indicated at 37uC for 30 minutes prior to stimulation with DTT or
vitamin C. Capillary-like tube formation was observed with
a Nikon inverted microscope and the results recorded digitally
using Optimas image analysis software (Media Cybernetics).
Western blotting
Confluent PAEC grown on 6-well plates were treated as indicated
in medium containing 0.2% BSA for 15 minutes at 37uC. The
cells were lysed on ice in RIPA buffer (UpState) containing
phosphatase and protease inhibitors (Sigma) and insoluble protein
removed by centrifugation at 13,000 g for 5 min. The protein
concentration of samples was estimated using the DC Protein
Assay (BioRad) and 30 mg protein from each lysate was mixed
with 26 Llamelli sample buffer, separated by 10% SDS–PAGE
and semi-dry electroblotted onto nitrocellulose membrane. The
blots were blocked for 1 hour in 10% fat-free milk powder in Tris-
buffered saline containing 0.1% Tween 20 (TBS-T) and the
membranes incubated with a 1:1000 dilution of rabbit anti-
phospho-serine-1177 eNOS or anti-eNOS polyclonal antibodies,
(Cell Signalling) overnight at 4uC. After washing with TBS-T, the
membranes were incubated for 1 hour with a 1:5000 dilution of
peroxidase-labelled goat anti-rabbit polyclonal antibodies (Vector
Laboratories) at room temperature. The membranes were then
washed with TBS-T, and antibody binding visualised by enhanced
chemiluminescence (Amersham Biosciences).
Statistics
All data are expressed as the mean6SEM. Statistical analysis was
performed using the two-tailed Student’s t-test and p,0.05 was
considered statistically significant.
RESULTS
NO release in endothelial cells in the absence of
eNOS activation
To investigate the effect of DTT or vitamin C on NO-release in
endothelial cells, PAEC were grown to confluence and incubated
with varying concentrations of DTT and vitamin C for 1 hour.
Both DTT and vitamin C induced a similar concentration-
dependent increase in NO release from PAEC cultures (Fig. 1A).
Following treatment with 500 mmol/L DTT or vitamin C NO-
release was found to be 40065.55% and 344.5612.5% re-
spectively, above control values (Fig. 1B).
Endothelial NOS is the major source of NO produced by
endothelial cells [1]. To determine whether the NO released
following incubation of PAEC with DTT or vitamin C is generated
by eNOS, we pre-incubated PAEC with the eNOS inhibitors L-
NNA (500 mM) or L-NIO (10 mM) for 30 minutes prior to the
addition of DTT or vitamin C. Interestingly, both L-NNA (Fig. 1B)
and L-NIO (data not shown) failed to block the NO release induced
byDTTorvitamin C,indicating thatthe increase inNOrelease was
independent of eNOS activity. Consistent with these findings DTT
Figure 2. The effect of DTT on in vitro tube formation. A Endothelial cells grown on growth factor-reduced Matrigel were stimulated with (I) the
vehicle alone (control) and with (II) 10, (III) 100, (IV) 200, (V) 500, and (VI) 1000 mM DTT. Cells were observed 24 hours after stimulation and results
recorded digitally. B Quantitative analysis of the results representing the mean total tube length per 406field. The results are the mean (6SEM, bars)
of three different fields. *, p,0.01 versus 200 mM DTT.
doi:10.1371/journal.pone.0000025.g002
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phosphorylation of eNOS at serine-1177, which is required for its
activation (Fig. 1C) [23]. In contrast, PAEC stimulated with the
PKC activator, phorbol myristate acetate (PMA; 100 nmol/L)
showed a 5-fold increase in eNOS phosphorylation (Fig. 1C).
Finally, we examined the effect of DTT and vitamin C on the
level of S-nitrosothiols in PAEC. Cells were incubated with
500 mM DTT or 500 mM vitamin C for 1 hour, and the extracted
proteins Western blotted with an anti-S-nitrosothiol antibody. The
blots show S-nitrosylated proteins ranging from approximately 15
to 250 kDa in PAEC (Fig. 1D). Pre-incubation of PAEC with the
NO donor, SNAP, increased the level of S-nitrosoproteins (Fig. 1D)
in these cells, which was reduced in some of these proteins by the
addition of 500 mM DTT, or 500 mM vitamin C for 1 hour
(Fig. 1D). The presence of biologically relevant transition metals
such as copper has been shown to promote the decomposition of
S-nitrosothiols mediated by vitamin C [24,25]. Addition of
100 mM CuSO4 with vitamin C to PAEC produced a 20%
increase in NO release over that of vitamin C alone (data not
shown). This further supports our findings indicating that this NO
release is occurring independently of eNOS activation.
DTT and vitamin C induce capillary-like tube
formation
To investigate whether the observed increase in free NO following
incubation with DTT or vitamin C can affect endothelial cell
function, we plated PAEC on growth factor reduced Matrigel and
examined their ability to form capillary-like tube networks. The
degree of networK formation was quantified by measuring the
mean total tube length per 406field. Increasing the concentration
of DTT above 10 mM produced a concomitant increase in the
degree of arrangement of PAEC into tubular networks (Fig. 2). At
1 mM DTT, PAEC reorganised into complete tubular networks
(Fig. 2A VI), whereas no tube formation was observed with
10 mmol/L DTT (Fig. 2A II) or under control conditions (Fig. 2A
I). There was a ,15-fold increase in mean total tube length
(Fig. 2B, p,0.01, n=5) with 1 mM DTT compared with that
observed with 200 mM DTT.
As DTT strongly induced the organisation of PAEC into tube
networks, we investigated the long-term effect of 1 mM on in vitro
angiogenesis. Interestingly, DTT maintained PAEC tube networks
for approximately one month in serum-free medium. Over time
we observed a significant increase in the thickness of the tube
structures (Fig. 3A II–VI) and concomitant reduction in mean total
tube length (Fig. 3B; P,0.05, n=5).
The effect of increasing concentrations of vitamin C on the
formation of tubular structures by PAEC was monitored in the
presence of 10 mM copper. After 24 hours incubation, vitamin C
at 500 mM stimulated a 2-fold increase in tube length (Fig. 4). The
capillary networks collapsed and the cells dispersed into the
surrounding medium after 48 hours (data not shown). The
addition of 10 mM copper sulphate alone induced a 2-fold
increase in total tube length compared with untreated cells, which
Figure 3. The long-term effect of DTT on capillary-like tube formation. A Porcine aortic endothelial cells were seeded on growth factor-reduced
Matrigel and stimulated with the vehicle alone for 1 day (I) or 1 mM DTT (II–V) and observed at (II) 1, (III) 7, (IV) 14, (V) 21, and (VI) 28 days. B
Histograms showing the quantitative analysis of the mean total tube length per 406field. Results are the mean (6SEM, bars) of three different fields.
*, p,0.01;**, p,0.001 versus control.
doi:10.1371/journal.pone.0000025.g003
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In contrast to DTT, vitamin C produced incomplete tube
networks consisting of short tubular-like structures, even at
concentrations of 1 mM (Fig. 4A and data not shown).
DTT- induced tube formation is dependent on
guanylyl cyclase and PKG activity
To investigate the mechanism(s), by which DTT and vitamin C
promote capillary-like tube formation, PAEC were pre-incubated
for 30 minutes with inhibitors of eNOS (L-NNA and L-NIO),
guanylyl cyclase (ODQ) and PKG (KT-5823) prior to stimulation.
The results of these experiments are summarised in Fig. 5 and
show that the tube formation stimulated by DTT (Fig. 5A and B)
or vitamin C (Fig. 5E) is independent of eNOS activity. As many of
the activities of NO are dependent on guanylyl cyclase and its
downstream effector PKG we investigated their effect on DTT
and vitamin C induced tube formation. ODQ (10 mM) and KT-
5823 (1 mM) significantly reduced the ability of DTT to induce
tube formation, implicating the guanylyl cyclase-PKG pathway in
this process (Fig. 5C and D). In contrast to DTT, the effect of
vitamin C was not abrogated by the same concentration of ODQ
and KT-5823 indicating that guanylyl cyclase and PKG are not
required for its activity (Fig. 5E).
DISCUSSION
In this study we show that the antioxidants DTT and vitamin C
can release sufficient NO from PAEC cultures to promote in vitro
angiogenesis via cGMP dependent and independent pathways.
The pro-angiogenic activity of several growth factors, including
the VEGF family and angiopoietins, is dependent on eNOS
activity [6–9,26]. The requirement of NO for VEGF-mediated
angiogenesis was highlighted by studies of eNOS
(2/2) knock-out
mice in which VEGF fails to induce neovascularisation [6,7].
Similarly, VEGF-stimulated endothelial cell capillary-like tube
network formation in vitro requires activation eNOS leading to NO
release and is reported to be dependent on the subsequent
generation of the second messenger cGMP [8,9]. Consistent with
these findings the rearrangement of PAEC into capillary-like tube
networks in response to DTT was found to be dependent on
guanylyl cyclase and PKG activity confirming that cGMP is a key
mediator of in vitro angiogenesis.
Thiol depletion has been shown to inhibit eNOS activity and
subsequent NO production in endothelial cells [27] and the rat
aorta [28]. In human umbilical vein endothelial cells the removal
of glutathione with 1-chloro-2,4-dinitrobenzene dramatically de-
creased the generation of citrulline, a by-product of NO synthesis,
and was reversed by the addition of reduced glutathione [27].
Similarly, the oxidation of intracellular thiols in PAEC using
Figure 4. The effect of vitamin C on capillary-like tube formation. A Porcine aortic endothelial cells seeded on growth factor-reduced Matrigel were
stimulated with either the vehicle alone (I), 10 mM CuSO4 (II), 200 mM vitamin C (III), 200 mM vitamin C and 10 mM CuSO4 (IV), 500 mmol/L mmol/L
vitamin C (V) and 500 mM vitamin C and 10 mM CuSO4 (VI), for 24 hours. B Histogram showing the mean total tube length per 406field. The results
are the mean (6SEM, bars) of three different fields of three independent experiments.
doi:10.1371/journal.pone.0000025.g004
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PLoS ONE | www.plosone.org 5 December 2006 | Issue 1 | e25Figure 5. DTT-induced capillary-like tube formation is dependent on guanylyl cyclase and PKG activity. Porcine aortic endothelial cells (PAEC)
plated on growth factor-reduced Matrigel were pre-incubated for 30 minutes with the NOS inhibitors, L-NNA (500 mM) and L-NIO (10 mM), guanylyl
cyclase inhibitor, ODQ (10 mM), or PKG inhibitor, KT-5823 (1 mM), at 37uC in medium containing 0.2% BSA prior to stimulation with 500 mM DTT or
vitamin C for 24 hours. A Vehicle alone (I), DTT (II), DTT and L-NNA (III), DTT and L-NIO (IV), B Histogram showing the mean total tube length per 406
field of PAEC following stimulation with DTT in the presence of L-NNA and L-NIO following 24 hour incubation. C Vehicle alone (I), DTT (II), DTT and
ODQ (III), DTT and KT-5823 (IV), D Histogram showing the mean total tube length per 406 field of PAEC following stimulation with DTT in the
presence of ODQ or KT-5823 following 24 hour incubation. E Histogram showing the mean total tube length per 406 field of PAEC following
incubation with vitamin C in the presence of L-NNA, L-NIO, ODQ or KT-5823. The results are the mean (6SEM bars) of three different fields.
doi:10.1371/journal.pone.0000025.g005
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activity, which was completely restored by DTT [29]. In addition,
DTT was shown to directly activate oxidised purified bovine
eNOS in vitro [29]. However, in our assays PAEC were not
deliberately exposed to thiol depleting agents or direct oxidative
stress. In addition, DTT- and vitamin C-mediated NO-release was
not blocked by NOS inhibitors (Fig. 1) suggesting that NO was
being released from S-nitrosothiol reservoirs.
S-nitrosoproteins have been detected in many cell types
including the endothelium [14]. The presence of increasing
concentrations of reducing agents such as vitamin C and cysteine
leads to the rapid release of NO and progressive decrease in
detectable S-nitrosoproteins [14,19,25]. This process is enhanced
by the presence of biologically relevant reduced transition metals
such as copper and iron [24,25]. These findings are in general
agreement with our observations of the release of NO from S-
nitrosothiols in PAEC cultures following treatment with DTT and
vitamin C (Fig. 1A and B) was independent of NOS activation.
This was demonstrated by the increase of NO-release from
endothelial cell cultures pre-treated with the NOS inhibitors L-
NNA and L-NIO, and also a lack of eNOS phosphorylation at
serine-1177, which is required for full activation of the enzyme
[23], following stimulation with DTT and vitamin C. Further-
more, vitamin C-mediated NO-release and tube formation was
enhanced by the addition of copper ions. This is consistent with
the reported release of NO from S-nitrosoalbumin following the
addition of vitamin C and free copper [25].
Relative differences in reducing activity may account for the
profound difference in the ability of DTT, and vitamin C to
induce and maintain tube formation. Vitamin C stimulated the
formation of PAEC into tube networks, which were established
following overnight incubation. The extent of vitamin C-induced
tube network formation decreased after 24 hours and had
disappeared by 48 hours. In contrast, DTT stimulated the
formation of complete tubular networks that were strikingly
maintained for up to a month. While DTT required guanylyl
cyclase and PKG activity to induce tube formation (Fig. 5) the
activity of vitamin C was independent of cGMP. The mechanisms
underlying the long-term maintenance of DTT-stimulated tube
networks require further investigation.
Our demonstration that vitamin C induces capillary-like tube
formation are consistent with a previous study by May and
colleagues [30] demonstrating that vitamin C enhances the
synthesis of collagen type-IV in endothelial cells, which is
associated with the initial phases angiogenesis involving endothe-
lial cell migration and proliferation [31]. Conversely, Ashino and
co-workers [32] report that vitamin C inhibited the formation of
bovine pulmonary endothelial cell tube networks on growth factor-
reduced Matrigel, at concentrations above 100 nM, and in the
chorioallantoic membrane assay [33]. A possible explanation for
this observation is that the endothelial cells were pre-treated with
vitamin C for 30 minutes prior to plating onto Matrigel which
may have limited their exposure to released NO, whereas in our
study vitamin C was added to the cells following plating onto
Matrigel and present for the duration of the experiment.
Antioxidants protect the body against the damaging effects of
free radicals that can overwhelm the endogenous antioxidant
systems in pathologies such as atherosclerosis and hypertension,
and promote endothelial cell apoptosis [16,33–36]. The oxidative
depletion of vascular thiols increases the production of reactive
oxygen species leading to apoptosis, which can be reversed by the
addition of reducing agents such as DTT [37–39]. Reactive
oxygen species can attenuate endothelium-dependent vasorelaxa-
tion [40,41] and NO generated through the activation of eNOS
can act as cardioprotective anti-oxidant preventing free radical
damage [42–44]. Vitamin C is reported to inhibit the production
of superoxide free radicals in pig coronary and rat mesenteric
arteries [45,46], promote blood vessel relaxation, lower blood
pressure and preserve NO bioavailability in endothelial cells
derived from apoE-deficient mice [47]. The clinical use of anti-
oxidants in cardiovascular disease and cancer however remains
controversial. Although small-scale clinical trails of vitamin C
showed a significant improvement in endothelial function in
patients with coronary artery disease [48] and congestive heart
failure [49], large-scale randomised clinical trials of antioxidants in
the prevention of cardiovascular disease and cancer have
generated conflicting results. Vitamin C was reported to protect
against stroke and coronary heart disease [50,51], reduce blood
pressure [52] and decrease mortality [53]. The most recent and
comprehensive studies have shown no benefit from antioxidant
therapy [54–56]. Our study indicates that antioxidants may
promote angiogenesis through the release of NO from S-
nitrosothiols which could lead to potentially adverse effects in
pathologies such as cardiovascular disease where increased
angiogenesis in the adventitia/neointima leads to plaque instability
[57].
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